Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO) are archrivals thanks to their dueling drugs for weight loss, Zepbound and ...

Shares of Novo Nordisk (NVO) slipped on Friday following a note from JPMorgan's Richard Vosser. Vosser warned that the ...

Medical researchers have found that people who take the semaglutide-based drugs Ozempic and Wegovy may be less likely to die ...

Benzinga examined the prospects for many investors’ favorite stocks over the last week — here’s a look at some of our top ...

On Tuesday, congressional leaders spent two hours taking to task Novo Nordisk Chief Executive Officer Lars Fruergaard ...

Researchers attempt to identify 15 Medicare Part D drugs with the highest risk of facing the U.S. government's ...

Plus the week included a stop in Detroit by Lael Brainard, the director of the National Economic Council, who spoke to the ...

Hundreds of Americans have filed lawsuits in multiple states against pharmaceutical giants Novo Nordisk and Eli Lilly, ...

Thousands of plaintiffs have sued Ozempic manufacturers for failing to warn them about the risk of stomach paralysis.

Evotec SE, a life science company, has entered a technology development partnership with Novo Nordisk in cell therapy. Both Evotec and Novo Nordisk have significant expertise and a strategic focus to ...

In this Saturday version of Insider Today, we're talking about Austin, Texas' real estate cycle and the price of weight-loss ...

European stocks face a series of hurdles to extend their 2024 rally after hitting another record high this week.Most Read ...